Literature DB >> 22615158

Bone delivers its energy information to fat and islets through osteocalcin.

Xiang Chen1, Hao-ming Tian, Xi-jie Yu.   

Abstract

Bone has emerged as a novel endocrine organ for its ability to produce hormones and involvement in several regulatory feedback loops. Osteocalcin (OCN) is released into bloodstream during bone resorption and has been demonstrated to exert endocrine regulation on islets, fat and male testis to form feedback loops. We hypothesize that bone delivers its energy metabolism signals to related energy-regulating organs through OCN based on the following evidence: First, OCN has close interactions with islets and fat, and it shows ability to stimulate islets and fat to secret insulin and adiponectin, respectively. Islets and fat are important organs involved in energy metabolism. Second, OCN undergoes physiological fluctuations during a lifetime. In children and adolescents, during the development of osteoporosis or after bone fracture, OCN level increases significantly. The elevated OCN at these stages represents enhanced bone turnover and metabolic activity, which require more energy supply. Therefore, the metabolic activity of bone and the energy-related organs like fat and islets are closely linked by circulating OCN. Through systemic release of OCN, bone delivers its energy-demanding information to other organs to satisfy its energy requirement.
© 2012 Tianjin Hospital and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615158      PMCID: PMC6583110          DOI: 10.1111/j.1757-7861.2012.00180.x

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  27 in total

1.  Serum leptin levels are associated with bone mass in nonobese women.

Authors:  J A Pasco; M J Henry; M A Kotowicz; G R Collier; M J Ball; A M Ugoni; G C Nicholson
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

Review 2.  Direct actions of leptin on bone remodeling.

Authors:  I R Reid; J Comish
Journal:  Calcif Tissue Int       Date:  2004-04       Impact factor: 4.333

3.  Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

Authors:  Xijie Yu; Omar A Ibrahimi; Regina Goetz; Fuming Zhang; Siobhan I Davis; Holly J Garringer; Robert J Linhardt; David M Ornitz; Moosa Mohammadi; Kenneth E White
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

4.  Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo.

Authors:  J Cornish; K E Callon; U Bava; C Lin; D Naot; B L Hill; A B Grey; N Broom; D E Myers; G C Nicholson; I R Reid
Journal:  J Endocrinol       Date:  2002-11       Impact factor: 4.286

5.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

6.  Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling.

Authors:  Jan O Gordeladze; Christian A Drevon; Unni Syversen; Janne E Reseland
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

7.  Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.

Authors:  Masayuki Iki; Takashi Akiba; Toshio Matsumoto; Harumi Nishino; Sadanobu Kagamimori; Yoshiko Kagawa; Hideo Yoneshima
Journal:  Osteoporos Int       Date:  2004-07-31       Impact factor: 4.507

8.  Great increase in bone 66 kDa protein and osteocalcin at later stages with healing rat fractures: effect of zinc treatment.

Authors:  Aki Igarashi; Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2003-02       Impact factor: 4.101

9.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.

Authors:  T Thomas; F Gori; S Khosla; M D Jensen; B Burguera; B L Riggs
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

10.  Leptin inhibits osteoclast generation.

Authors:  Wayne R Holloway; Fiona McL Collier; Cathy J Aitken; Damian E Myers; Jason M Hodge; Mary Malakellis; Tamara J Gough; Gregory R Collier; Geoffrey C Nicholson
Journal:  J Bone Miner Res       Date:  2002-02       Impact factor: 6.741

View more
  2 in total

1.  The prognostic value of elevated ezrin in patients with osteosarcoma.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Zhao-Wan Xu; Li-Na Xu; Bin-Wu Wang
Journal:  Tumour Biol       Date:  2013-09-07

Review 2.  Fat and bone interactions.

Authors:  Sandra Bermeo; Krishanthi Gunaratnam; Gustavo Duque
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.